Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Timothy Boehm v. Eli Lilly & Company
Case Number:
13-1350
Court:
Nature of Suit:
4365 Personal Injury-Product Liability
Sectors & Industries:
-
April 16, 2014
8th Circ. Won't Rehear Eli Lilly Failure-To-Warn Suit En Banc
The Eighth Circuit on Tuesday refused to rehear en banc a ruling that cleared Eli Lilly & Co. of failing to warn that long-term users of the antipsychotic drug Zyprexa risk developing an involuntary movement disorder.
-
March 10, 2014
Eli Lilly Beats Zyprexa Failure-To-Warn Suit In 8th Circ.
The Eighth Circuit on Monday upheld a victory for Eli Lilly & Co. in a lawsuit claiming it failed to adequately warn of the risks of long-term use of the antipsychotic drug Zyprexa, backing a lower court's exclusion of expert testimony.